Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries : part B: recommendations for the clinical management of hypertension
Clinical management of hypertension in patients with autoimmune rheumatic diseases (ARDs) is challenging. Firstly, the impact on blood pressure (BP) of several antirheumatic drugs varies and the available evidence points towards a wide range of effects. Secondly, management of hypertension in terms...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Article (Journal) |
| Lenguaje: | inglés |
| Publicado: |
August 2026
|
| In: |
Journal of hypertension
Year: 2026, Volumen: 44, Número: 8, Pages: 1308-1321 |
| ISSN: | 1473-5598 |
| DOI: | 10.1097/HJH.0000000000004347 |
| Acceso en línea: | Verlag, kostenfrei, Volltext: https://doi.org/10.1097/HJH.0000000000004347 Verlag, kostenfrei, Volltext: https://www.ovid.com/jnls/jhypertension/fulltext/10.1097/hjh.0000000000004347~hypertension-in-autoimmune-rheumatic-diseases-a-position 
|
| Notas de Autor: | Eugenia Gkaliagkousi, Michael Doumas, Antonios Lazaridis, Carolina de Ciuceis, Claudia Agabiti-Rosei, Krzysztof Narkiewicz, Panagiota Anyfanti, Anastasia Malliora, Konstantinos Stellos, Nikolaos Vlachogiannis, Maria S. Stoenoiu, Konstantinos Stavropoulos, Theodoros Dimitroulas, Georgios Mavraganis, Kimon Stamatelopoulos, Dimitrios Terentes-Printzios, Ignatios Ikonomidis, Francisco Rios, Barbara Anna Kutryb-Zając, Francesco Paneni, Alessandro Mengozzi, Ryszard Nosalski, Georgios Georgiopoulos, George Pavlidis, Simon Tual-Chalot, Livia Camargoa, Federica Cappelli, Edyta Dąbrowska, Fosca Quarti-Trevano, Marcin Hellmann, Stefano Masi, Augusto Montezano, Pawel Winklewski, Jacek Wolf, Sarah Costantino, Ines Drenjančević, Stefano Taddei, Tomasz Guzik, Reinhold Kreutz, Christian Delles, Rhian Touyz, Alexandre Persu, Thomas Weber, Margus Viigimaa, Guido Grassi, Agostino Virdis |
| Sumario: | Clinical management of hypertension in patients with autoimmune rheumatic diseases (ARDs) is challenging. Firstly, the impact on blood pressure (BP) of several antirheumatic drugs varies and the available evidence points towards a wide range of effects. Secondly, management of hypertension in terms of diagnosis, BP thresholds and therapeutic targets currently follows the general recommendations, even though patients with ARDs present a markedly adverse cardiovascular profile. Thirdly, lifestyle interventions in terms of non-pharmaceutical management follow the general recommendations. Notably, it has been shown that they can improve autoimmune disease-specific endpoints, however, their intimate effect on BP has not been fully explored. Finally, the choice of anti-hypertensive medication currently complies with the general antihypertensive therapy recommendations, in the absence of appropriately designed studies in these populations. This review aims to summarize the impact of antirheumatic drugs on BP and present the available data regarding clinical management of hypertension in patients with ARDs. |
|---|---|
| Notas: | Gesehen am 21.07.2026 |
| Descripción Física: | Online Resource |
| ISSN: | 1473-5598 |
| DOI: | 10.1097/HJH.0000000000004347 |